Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of ulipristal versus leuprorelin in symptomatic uterine fibroids
jRCT2080223680Phase 3Completed
- Sponsor
- ASKA Pharmaceutical Holdings Co., Ltd.
- Start
- Oct 2017
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ulipristal and leuprolide in Fibromyoma (LM) (2 arms), sponsored by ASKA Pharmaceutical Holdings Co., Ltd. Primary endpoint: Percentage of subjects with amenorrhea. Started Oct 2017; status: completed.
02
Drugs
ulipristalleuprolide
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on jRCT2080223680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223680.